Dive deep into a detailed comparison between ALGN and PAYC for novice swing traders. Understand how 'Exits from Low Volatility to Explosive Movements' returns 6.32% for ALGN, while 'Trading in Markets Trending Up' fetches 6.58% for PAYC. Explore with us!
Take advantage of our AI Trading Bot which consistently generates a gain of 12.79% for BNGO stocks. Perfect for swing traders, this high-volatility stock trading tool delivers impressive results. Try the innovative version 2.0 today and step up your trading game.
In the realm of AI-driven trading robots, the Swing trader: Deep Trend Analysis v.2 (TA) has emerged as one of the standout performers in our robot factory. Over the previous week, this particular AI trading robot showcased its prowess by generating a remarkable 3.42% gain through its strategic trading of BNGO. However, as we delve deeper into the technical indicators and earnings results, it becomes evident that a price pull-back may be on the horizon.
ALGN stock may rebound above the lower band and target the middle band, presenting a potential buying opportunity. Learn how an AI trading bot generated impressive gains of 17.09% and explore stock purchase or call option strategies. Gain expert insights and analysis for successful trading.
This AI trading robot, available at Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA), was a top performer in our robot factory, generating 21% for XRAY over the past 6 months.
Bionano Genomics stocks rose by over 14% ($0.81) yesterday, and our robots were quick to spot this opportunity, generating more than a 10% profit on this stock in just one day. We'd like to highlight our Swing Trader Volatility Balanced Strategy v2 TA robot, which is gaining momentum once again.
West Pharmaceutical Services (WST) indicate a 2% growth to $373.2 or more within the next week, with a 74% chance of an uptrend continuation. However, investors should also be aware of the recent bearish sign, as WST has been in a downward trend for three consecutive days. A.I.dvisor's data shows that in the past, when WST declined for three days, the price declined further within the following month in 49% of cases. To maximize your gains and minimize your risk, it's important to consider both short-term and long-term investment strategies. Learn more in our latest analysis.
Investors are increasingly turning to Swing Trader: High Volatility Stocks for Active Trading (TA&FA), to improve their trading performance, and one such robot has been generating impressive returns for investors. In the previous month, an AI trading robot generated a 5.80% profit for BNGO.
On Thursday, March 2, 2023, Cooper Companies, a major producer of contact lenses and medical equipment, is scheduled to release its financial results. The business has had a successful year, and its stock price has been steadily rising. Recent market signs, however, indicate that the stock may be changing from an upward to a bearish trend. The 10-day RSI Indicator for COO moved out of...
EssilorLuxottica SA posted third quarter revenue of 6.39 billion euros ($6.25 billion), which is +17% higher (+8.2% at constant currency rates). The figure is in line with analysts' expectations (based on FactSet poll). The luxury eyecare company’s revenue from North America rose +20.5% (+3.4% at constant currency rates) from the year-ago quarter, while those from EMEA were up +7.6%...
Hexo posted its fiscal third-quarter revenue of C$45.6 million, which is +101% higher from a year earlier. However, it fell -14% quarter-over-quarter. The cannabis company reported an adjusted loss of C$-0.045 a share, in line with expectations of analysts polled by Investing.com. According to the company, its 450 staff retrenchments will lower sales and administrative expenses by 30%, or...
Cooper Companies reported its quarterly earnings results that surpassed analysts’ expectations. The medical device company’s earnings came in at $3.24 a share for the quarter, above the Zacks’ consensus estimate of $3.10. The figure was $3.17 per share a year ago. Cooper Companies revenue rose +15.7% from the year-ago quarter to $787.20 million, also exceeding analyst estimates of $739.30...
Cannabis company HEXO Corp. posted a loss of -$93.3 million or -37 cents in its fiscal first quarter. Losses, adjusted for asset impairment costs and costs related to mergers and acquisitions, were -9 cents per share. The result was better than the -10 cents per share loss expected by analysts surveyed by Zacks Investment Research. The company’s adjusted revenue for the quarter came in at...
Hexo reported its latest quarterly revenue that beat analysts’ expectations.
The cannabis company’s revenue for the quarter ended April 30 came in at $16.3 million, compared to the $14.9 million that Zacks Investment Research had predicted.The result also surpassed FactSet’s estimate of just under $15 million.
The company’s revenue got a major boost from sales of the "Original Stash" brand.
Overall, adult-use cannabis revenue climbed to $22.07 million, up from a little over $17 million in the previous quarter and $10.8 million in the year-ago quarter.
Hexo’s gross margins increased by 40%.
Baxter International Inc. reported preliminary third-quarter 2019 revenues of $2.85 billion, which were lower than the Zacks Consensus Estimate of $2.86 billion.However, the figure was +3% higher compared to the year-ago quarter, on a reported basis.
Intuitive Surgical beat analysts' estimates on earnings for its latest quarter, while also surpassing revenue expectations.
The robotic surgery company reported earnings of $3.43 a share in the third quarter, compared to analysts’ expectation of $2.96 (based on survey by Zacks Investment Research).
Intuitive Surgical had a +21.2% gain in adjusted EPS during the third quarter compared to the same period a year ago.
Revenue increased +22.5% year-over-year for the to $1.13 billion, which exceeded the $1.06 billion expected by analysts (polled by Zacks).
"
The cannabis company said that it expects fourth-quarter revenue to range between C$14.5 million to C$16.5 million ($10.9 million to $12.4 million), below Wall Street's forecast of C$24.8 million ($18.6 million).For the full-year, the company projects revenue to range between C$46.5 million and C$48.5 million ($34.9 million to $36.4 million).
Hexo was withdrawing its 2020 financial outlook due to regulatory uncertainty across the pan-Canadian system, and jurisdictional decisions that it thinks will limit the availability and types of cannabis derivative products.
"While we are disappointed with these results, we are making significant changes to our sales and operations strategy to drive future results," said Sebastien St-Louis, Hexo's CEO and co-founder.
On Monday, Michael Monahan, Hexo’s chief financial officer, resigned from the company, due to his "family's needs."
AngioDynamics shares plummeted on Thursday, after the company released its latest guidance for the full-year.
The medical devices maker announced the purchase of Israeli laser company Eximo for $46 million up front, with up to another $20 million conditional upon Eximo meeting its technical and revenue milestones.
Following the acquisition, AngioDynamics now expects earnings for fiscal 2020 to range between 10 cents and 15 cents a share – a range lower than analysts’ expectation of 26 cents.
Angio CEO Jim Clemmer indicated that the acquisition of Eximo would usher in a remarkable, foundational technology for its portfolio in a way that transforms the way caregivers provide treatment to patients with PAD. "The market is ripe for disruption, and the level of precision, safety, and efficiency offered to physicians by this laser technology creates a substantially differentiated alternative to legacy atherectomy devices," Clemmer said.
Separa
Aerie Pharmaceuticals, Inc.announced that it has initiated the dosing in a phase II study on netarsudil ophthalmic solution in Japan for reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Read more...